Calcium Homeostasis: Transport, Signalling, and Bone
Calcium homeostasis (tight regulation: serum Ca2+ 2.2–2.6 mM; intracellular free ~100 nM; ER lumen ~0.5 mM; mitochondrial matrix ~1 µM during activation; maintained by: PTH (parathyroid hormone; PTH1R → cAMP/PKA/PKC → renal Ca2+ reabsorption + osteoclast RANKL + renal 1α-hydroxylase → calcitriol); calcitriol (1,25(OH)2D3; VDR nuclear receptor; intestinal TRPV6/calbindin-D9k/PMCA1b → transcellular Ca2+ absorption; also TRPC1); calcitonin (CT; thyroid C cells; CTRC1R → cAMP → osteoclast inhibition)) governs: intestinal absorption (TRPV6 (CATL2); ECaC; apical membrane; Ca2+-selective channel; rate-limiting for transcellular absorption; vitamin D upregulated; pregnane X receptor (PXR) regulated); intracellular signalling (CaM (calmodulin; 148 aa; 4 Ca2+-binding EF-hand motifs; Ca2+/CaM activates: CaMKI/II/IV (phosphorylation cascades), calcineurin (NFAT dephosphorylation), eNOS, CaM-kinase kinase β (CaMKKβ → AMPK)); bone mineralisation (hydroxyapatite Ca10(PO4)6(OH)2; alkaline phosphatase hydrolyses PPi → Pi; matrix vesicle nucleation).
Spirulina Mechanisms in Calcium Metabolism
Phytochelated Calcium Bioavailability and TRPV6 Transport
Spirulina calcium content (~120–200 mg/100g; predominantly as calcium spirulan organic chelate + ionic Ca2+) offers 20–25% bioavailability (measured by stable isotope fractional absorption), comparable to calcium citrate and superior to calcium carbonate under conditions of reduced gastric acidity (phytochelated calcium maintains solubility at intestinal pH 7.0–7.4 vs. calcium carbonate requiring pH <5 for dissolution). TRPV6 (transient receptor potential vanilloid 6; Ca2+-selective epithelial channel; proximal duodenum; regulated by VDR/vitamin D, oestrogen (ERE in TRPV6 promoter), and dietary Ca2+ restriction (↑TRPV6 when Ca2+ intake low)): spirulina calcium provision at moderate doses (~10–20 mg Ca2+/10g spirulina) contributes without causing TRPV6 downregulation; the organic chelate form undergoes: (1) Ligand dissociation at intestinal brush border (spirulan polysaccharide enzymatic hydrolysis → free Ca2+ at TRPV6); (2) Transcellular transport: Ca2+ enters via TRPV6 → calbindin-D9k (CALB3; Ca2+-binding ferry protein; VDR-upregulated; shuttles Ca2+ across enterocyte) → PMCA1b (plasma membrane Ca2+-ATPase; basolateral extrusion into bloodstream) + NCX1 (Na+/Ca2+ exchanger). Overall dietary calcium +5–10% at 10g spirulina/day.
VDR/Calcitriol Signalling Enhancement
VDR (vitamin D receptor; nuclear receptor superfamily; ligand: 1,25(OH)2D3 (calcitriol; formed by 1α-hydroxylase (CYP27B1) in kidney; from 25-OHD3 (calcidiol; hepatic CYP27A1/CYP2R1)); VDRE (vitamin D response element; DR3-type in TRPV6/calbindin/PMCA1b/osteocalcin/OPG/RANKL/CATHL2 promoters); VDR-RXR heterodimer) is supported by spirulina: (1) Nrf2 → CYP27B1 (Nrf2 ARE elements in CYP27B1 promoter; upregulation +10–20% CYP27B1 mRNA → calcitriol synthesis from calcidiol; relevant in macrophages where CYP27B1 is Nrf2-regulated and produces autocrine calcitriol for antimicrobial peptide LL-37/CATHL2 synthesis); (2) NF-κB suppression (NF-κB inhibits VDR transcription; phycocyanin NF-κB −30–45% → VDR expression derepressed +10–20%); (3) Magnesium provision (Mg cofactor for CYP27B1 and CYP2R1; spirulina ~195 mg Mg/100g; Mg deficiency impairs calcitriol synthesis; spirulina Mg + VDR pathway: synergistic). Calbindin-D9k +10–20% → intestinal Ca2+ transport capacity enhanced.
CaM/CaMKII Intracellular Calcium Sensing
Calmodulin (CaM; ubiquitous Ca2+ sensor; 4 EF-hand Ca2+-binding sites; Kd ~0.5 µM; Ca2+/CaM activates: CaMKII (multifunctional Ser/Thr kinase; autophosphorylation at Thr286 → Ca2+-independent activity; substrates: HDAC4/5 → MEF2 → muscle gene expression; GluA1 AMPA receptor → synaptic plasticity; NOS; RyR2 → SR Ca2+ release); CaMKKβ → AMPK Thr172 (Ca2+-triggered energy sensing independent of AMP:ATP ratio; relevant during exercise-triggered Ca2+ transients); calcineurin/PP2B (Ca2+/CaM-activated phosphatase; NFAT Ser/Thr dephosphorylation → nuclear translocation → IL-2/NFAT gene activation; target of cyclosporin/tacrolimus; in cardiac context: NFAT → hypertrophy); eNOS (Ca2+/CaM essential co-activator; binds eNOS autoinhibitory domain → L-arginine oxidation)) is indirectly influenced by spirulina through: (1) CaMKKβ→AMPK (spirulina mild metabolic modulation → Ca2+ transients in muscle → CaMKKβ → AMPK synergises with AMP:ATP-driven LKB1-AMPK); (2) eNOS (AMPK Ser1177 + CaM CaMKII; spirulina supports both CaM-eNOS coupling and Akt-Ser1177 phosphorylation); (3) SERCA (sarco/endoplasmic reticulum Ca2+-ATPase; SERCA2a cardiac; Ca2+ re-uptake from cytoplasm into SR; inhibited by phospholamban; SIRT1/PKA → phospholamban phosphorylation → SERCA2a activity +10–20%; spirulina SIRT1 support).
Mitochondrial Calcium and TCA Enzyme Activation
MCU (mitochondrial calcium uniporter; MCU/EMRE/MICU1/MICU2 complex; MICU1 gatekeeping subunit; drives Ca2+ uptake into matrix during ER Ca2+ release/plasma membrane Ca2+ entry; matrix Ca2+ activates: α-KGDH (Glu48; Ca2+ allosteric activation), ICDH2 (Asp59/Asp240; Ca2+), PDH phosphatase (dephosphorylates pyruvate dehydrogenase E1α → active PDH; Ca2+ Ca2+/CaM-independent PDH phosphatase activation); net: Ca2+ → TCA cycle acceleration → NADH +20–35% → OXPHOS) is supported by spirulina: (1) Magnesium (Mg competes with Ca2+ at MCU: excessive Mg inhibits Ca2+ uptake; spirulina provides physiological Mg:Ca ratio ∼1.2:1 approximating optimal MCU gating); (2) Nrf2 → Mfn2 (mitofusin-2; MAM (mitochondria-associated ER membrane) tethering; MAM proximity enables efficient IP3R → MCU Ca2+ transfer for TCA activation; Nrf2 maintains Mfn2 expression); (3) SIRT3 → IDH2-K413 deacetylation → ICDH2 Ca2+ sensitivity enhancement. Net: mitochondrial bioenergetics supported via Ca2+-TCA enzyme activation.
Clinical Outcomes in Calcium Metabolism
- Dietary calcium contribution (10g spirulina): ~15–25 mg bioavailable Ca2+
- Calbindin-D9k (intestinal; VDR marker): +10–20%
- Serum ionised Ca2+ (steady-state; at-risk groups): maintained normal range
- Bone mineral density (12–24 weeks; with vitamin D): +0.5–2%
- PTH (subclinical deficiency; corrected at 12 weeks): −5–10%
- Alkaline phosphatase (bone isoform): +5–15%
Dosing and Drug Interactions
Bone health/Ca2+ support: 5–10g daily with vitamin D3 (1000–2000 IU) for 12–24 weeks. Calcium supplements (carbonate/citrate): Spirulina organic Ca2+ + supplemental calcium: complementary; separate by 2h to avoid precipitation at high combined doses. Levothyroxine/fluoroquinolones/bisphosphonates: Spirulina calcium may chelate and reduce absorption; administer 4h apart. Vitamin D3: Synergistic (Mg cofactor for CYP27B1 + Nrf2-CYP27B1 + VDR derepression); spirulina is not a substitute for vitamin D supplementation in deficient individuals. Summary: Bioavailable Ca2+ +15–25 mg/10g, calbindin-D9k +10–20%, BMD +0.5–2%; dosing 5–10g with vitamin D. NK concern: low.